USCA RIA’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$3.58M Buy
9,385
+65
+0.7% +$24.8K 0.22% 132
2021
Q1
$3.35M Buy
+9,320
New +$3M 0.22% 129
2018
Q3
Sell
-11,785
Closed -$2.81M 476
2018
Q2
$2.81M Buy
+11,785
New +$2.73M 0.3% 99

Other funds holding ELV

USCA RIA's ELV Position: Q2 2021 in Review

USCA RIA increased its Elevance Health (ELV) stake by 0.7% in Q2 2021, buying an estimated $24.8K and bringing the position to 9,385 shares worth $3.58M. The position accounts for 0.22% of the portfolio, ranked #132.

USCA RIA first reported a position in ELV in Q2 2018 and has held it in 3 quarters since. 1,234 funds tracked by Wall St. Rank hold ELV as of Q2 2021.

  • USCA RIA held 9,385 shares of Elevance Health worth $3.58M as of Q2 2021.
  • USCA RIA bought 65 Elevance Health shares in Q2 2021, an estimated $24.8K.
  • Elevance Health made up 0.22% of USCA RIA's portfolio in Q2 2021, its #132 holding.
  • USCA RIA first reported a position in Elevance Health in Q2 2018 and has held it in 3 quarters since.
  • 1,234 funds tracked by Wall St. Rank held Elevance Health as of Q2 2021.

Based on USCA RIA's 13F filing for Q2 2021, filed 28 Jul 2021.